Literature DB >> 21669403

Characteristics of intranasal structures for endonasal dacryocystorhinostomy in asians.

Kyung In Woo1, Hyo-Sung Maeng1, Yoon-Duck Kim2.   

Abstract

PURPOSE: To describe the anatomic characteristics of structures adjacent to the lacrimal sac fossa and the standardized osteotomy method for endonasal dacryocystorhinostomy in Asians.
DESIGN: Retrospective noncomparative observational case series study.
MATERIALS AND METHODS: One hundred fifty-two eyes of 76 patients who had normal orbit computed tomographic scans were enrolled. The relationships of the uncinate process, the operculum of the middle turbinate, and the agger nasi cell to the lacrimal sac fossa were analyzed. Bone thickness and proportion of the frontal process of the maxilla in the lacrimal sac fossa was also evaluated.
RESULTS: The uncinate process was attached to the lacrimal sac fossa in 152 cases (100%) at the lower level of the fossa. The operculum of the middle turbinate was attached to the lacrimal sac fossa in 142 cases (93.4%), with wide positional variation. The agger nasi cell was adjacent to the lacrimal sac fossa in 118 cases (77.6%). The descent of the operculum of the middle turbinate relative to the lacrimal fossa had a strong correlation with the descent of the agger nasi cell (P < .001). The height and length of the nasal bone had a significant negative correlation with the thickness of the frontal process of the maxillary bone (P < .001).
CONCLUSION: The uncinate process, operculum of the middle turbinate, and agger nasi cell should be removed for sufficient osteotomy in a significant portion of Asian patients during dacryocystorhinostomy. A thick frontal process of the maxilla can be anticipated for the patient with a low nasal bridge. Further studies on the variation in intranasal procedures and the success rate of endonasal dacryocystorhinostomy need to be established.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21669403     DOI: 10.1016/j.ajo.2011.02.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Acute post-operative rhinosinusitis following endonasal dacryocystorhinostomy.

Authors:  P N Shams; D Selva
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

2.  Effects of ostium granulomas and intralesional steroid injections on the surgical outcome in endoscopic dacryocystorhinostomy.

Authors:  Aerin Jo; Shin-Hyo Lee; Wu-Chul Song; Hyun Jin Shin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

3.  Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy.

Authors:  Emmy Y Li; Andy C Cheng; Alex C Wong; Amy M Sze; Hunter K Yuen
Journal:  Int Ophthalmol       Date:  2015-05-26       Impact factor: 2.031

4.  New mucosal flap modification for endonasal endoscopic dacryocystorhinostomy in Asians.

Authors:  Qing-Shan Ji; Jing-Xiang Zhong; Yun-Hai Tu; Wen-Can Wu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

5.  Meet the Lacrimal Sac: Endoscopic Surgeons' Road Map.

Authors:  Amit Kumar Tyagi; Mary Kurien; Aparna Irodi; Ajoy M Varghese; Sunil J Holla; Regi Thomas
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-04-08

6.  Effects of nasopore packing on dacryocystorhinostomy.

Authors:  Sun Young Jang; Kyou Ho Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2013-02-27

7.  Anatomy of lacrimal sac fossa affecting success rate in endoscopic and external dacryocystorhinostomy surgery in Mongolians.

Authors:  Bayasgalan Purevdorj; Uranchimeg Dugarsuren; Bulgan Tuvaan; Baasankhuu Jamiyanjav
Journal:  Anat Cell Biol       Date:  2021-12-31

8.  Computed tomographic assessment of the lacrimal sac fossa in southwest population of Iran.

Authors:  Samad Shahryari; Mohammad Ghasem Hanafi; Rouhangiz Kamankesh; Atefeh Mahdianrad; Ali Reza Eftekhari Moghadam
Journal:  Anat Cell Biol       Date:  2022-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.